Protein folding;
Thermodynamic stability;
Binding affinity;
Heat shock protein 90;
Chemical denaturation;
Isobaric mass tags;
Protein-ligand binding;
Covalent labeling;
HSP90 MOLECULAR CHAPERONE;
PROTEIN;
90;
HSP90;
SACCHAROMYCES-CEREVISIAE;
CRYSTAL-STRUCTURE;
TERMINAL DOMAIN;
INHIBITION;
COMPLEX;
BINDING;
DERIVATIVES;
STABILITY;
D O I:
10.1007/s13361-016-1457-2
中图分类号:
Q5 [生物化学];
学科分类号:
071010 ;
081704 ;
摘要:
Geldanamycin is a natural product with well-established and potent anti-cancer activities. Heat shock protein 90 (Hsp90) is the known target of geldanamycin, which directly binds to Hsp90's N-terminal ATP binding domain and inhibits Hsp90's ATPase activity. The affinity of geldanamycin for Hsp90 has been measured in multiple studies. However, there have been large discrepancies between the reported dissociation constants (i.e., K-d values), which have ranged from low nanomolar to micromolar. Here the stability of proteins from rates of oxidation (SPROX) technique was used in combination with an isobaric mass tagging strategy to measure the binding affinity of geldanamycin to unpurified Hsp90 in an MCF-7 cell lysate. The K-d values determined here were dependent on how long geldanamycin was equilibrated with the lysate prior to SPROX analysis. The K-d values determined using equilibration times of 0.5 and 24 h were 1 and 0.03 mu M, respectively. These K-d values, which are similar to those previously reported in a geldanamycin-Hsp90 binding study that involved the use of a fluorescently labeled geldanamycin analogue, establish that the slow-tight binding behavior previously observed for the fluorescently labeled geldanamycin analogue is not an artifact of the fluorescent label, but rather an inherent property of the geldanamycin-Hsp90 binding interaction. The slow-tight binding property of this complex may be related to time-dependent conformational changes in Hsp90 and/or to time-dependent chemical changes in geldanamycin, both of which have been previously proposed to explain the slow-tight binding behavior of the geldanamycin-Hsp90 complex.
机构:
Mem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USA
Chiosis, G
Rosen, N
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USA
Rosen, N
Sepp-Lorenzino, L
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USA
机构:
Mem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USA
Chiosis, G
Rosen, N
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USA
Rosen, N
Sepp-Lorenzino, L
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Mol Oncogenesis, New York, NY 10021 USA